238 related articles for article (PubMed ID: 22998363)
1. Stepwise intensification of insulin therapy in type 2 diabetes management--exploring the concept of the basal-plus approach in clinical practice.
Owens DR
Diabet Med; 2013 Mar; 30(3):276-88. PubMed ID: 22998363
[TBL] [Abstract][Full Text] [Related]
2. Randomized, 1-year comparison of three ways to initiate and advance insulin for type 2 diabetes: twice-daily premixed insulin versus basal insulin with either basal-plus one prandial insulin or basal-bolus up to three prandial injections.
Riddle MC; Rosenstock J; Vlajnic A; Gao L
Diabetes Obes Metab; 2014 May; 16(5):396-402. PubMed ID: 24118931
[TBL] [Abstract][Full Text] [Related]
3. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH
Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076
[TBL] [Abstract][Full Text] [Related]
4. Prandial premixed insulin analogue regimens versus basal insulin analogue regimens in the management of type 2 diabetes: an evidence-based comparison.
Ilag LL; Kerr L; Malone JK; Tan MH
Clin Ther; 2007 Jun; 29(6 Pt 1):1254-70. PubMed ID: 18036388
[TBL] [Abstract][Full Text] [Related]
5. A comparison of intensive mixture therapy with basal insulin therapy in insulin-naïve patients with type 2 diabetes receiving oral antidiabetes agents.
Jacober SJ; Scism-Bacon JL; Zagar AJ
Diabetes Obes Metab; 2006 Jul; 8(4):448-55. PubMed ID: 16776752
[TBL] [Abstract][Full Text] [Related]
6. Effects of initiation and titration of a single pre-prandial dose of insulin glulisine while continuing titrated insulin glargine in type 2 diabetes: a 6-month 'proof-of-concept' study.
Owens DR; Luzio SD; Sert-Langeron C; Riddle MC
Diabetes Obes Metab; 2011 Nov; 13(11):1020-7. PubMed ID: 21679291
[TBL] [Abstract][Full Text] [Related]
7. Comparison of thrice-daily premixed insulin (insulin lispro premix) with basal-bolus (insulin glargine once-daily plus thrice-daily prandial insulin lispro) therapy in east Asian patients with type 2 diabetes insufficiently controlled with twice-daily premixed insulin: an open-label, randomised, controlled trial.
Jia W; Xiao X; Ji Q; Ahn KJ; Chuang LM; Bao Y; Pang C; Chen L; Gao F; Tu Y; Li P; Yang J
Lancet Diabetes Endocrinol; 2015 Apr; 3(4):254-62. PubMed ID: 25754414
[TBL] [Abstract][Full Text] [Related]
8. Attainment of glycaemic goals in type 2 diabetes with once-, twice-, or thrice-daily dosing with biphasic insulin aspart 70/30 (The 1-2-3 study).
Garber AJ; Wahlen J; Wahl T; Bressler P; Braceras R; Allen E; Jain R
Diabetes Obes Metab; 2006 Jan; 8(1):58-66. PubMed ID: 16367883
[TBL] [Abstract][Full Text] [Related]
9. Intensification of Gla-100 with Prandial Insulin: A Stepwise Progression Toward Glycemic Control.
Wangnoo SK; Damodharan S; Sastry NG; Bhattacharyya S; Selvan C; Mohan B; Sarmah C; Arivazhahan A; Mohan V
J Assoc Physicians India; 2020 Dec; 68(12[Special]):43-48. PubMed ID: 33247663
[TBL] [Abstract][Full Text] [Related]
10. Options for the intensification of insulin therapy when basal insulin is not enough in type 2 diabetes mellitus.
Raccah D
Diabetes Obes Metab; 2008 Jul; 10 Suppl 2():76-82. PubMed ID: 18577159
[TBL] [Abstract][Full Text] [Related]
11. Patients with type 2 diabetes inadequately controlled on premixed insulin: effect of initiating insulin glargine plus oral antidiabetic agents on glycaemic control in daily practice.
Hammer H; Klinge A
Int J Clin Pract; 2007 Dec; 61(12):2009-18. PubMed ID: 17997807
[TBL] [Abstract][Full Text] [Related]
12. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
13. Review of basal-plus insulin regimen options for simpler insulin intensification in people with Type 2 diabetes mellitus.
Raccah D; Huet D; Dib A; Joseph F; Landers B; Escalada J; Schmitt H
Diabet Med; 2017 Sep; 34(9):1193-1204. PubMed ID: 28574177
[TBL] [Abstract][Full Text] [Related]
14. Treatment intensification with stepwise addition of prandial insulin aspart boluses compared with full basal-bolus therapy (FullSTEP Study): a randomised, treat-to-target clinical trial.
Rodbard HW; Visco VE; Andersen H; Hiort LC; Shu DH
Lancet Diabetes Endocrinol; 2014 Jan; 2(1):30-7. PubMed ID: 24622667
[TBL] [Abstract][Full Text] [Related]
15. Comparison of biphasic insulin aspart 30 given three times daily or twice daily in combination with metformin versus oral antidiabetic drugs alone in patients with poorly controlled type 2 diabetes: a 16-week, randomized, open-label, parallel-group trial conducted in russia.
Ushakova O; Sokolovskaya V; Morozova A; Valeeva F; Zanozina O; Sazonova O; Zhadanova E; Starceva M; Kazakova E; Saifullina M; Shapiro I; Tarasov A; Al-Tayar B; Starkova N
Clin Ther; 2007 Nov; 29(11):2374-84. PubMed ID: 18158078
[TBL] [Abstract][Full Text] [Related]
16. Influence of preprandial vs. postprandial insulin glulisine on weight and glycaemic control in patients initiating basal-bolus regimen for type 2 diabetes: a multicenter, randomized, parallel, open-label study (NCT00135096).
Ratner R; Wynne A; Nakhle S; Brusco O; Vlajnic A; Rendell M
Diabetes Obes Metab; 2011 Dec; 13(12):1142-8. PubMed ID: 21812890
[TBL] [Abstract][Full Text] [Related]
17. Randomized, open-label, parallel-group evaluations of basal-bolus therapy versus insulin lispro premixed therapy in patients with type 2 diabetes mellitus failing to achieve control with starter insulin treatment and continuing oral antihyperglycemic drugs: a noninferiority intensification substudy of the DURABLE trial.
Miser WF; Arakaki R; Jiang H; Scism-Bacon J; Anderson PW; Fahrbach JL
Clin Ther; 2010 May; 32(5):896-908. PubMed ID: 20685497
[TBL] [Abstract][Full Text] [Related]
18. Insulin therapy for type 2 diabetes: premixed or basal-prandial?
Halbron M; Jacqueminet S; Sachon C; Bosquet F; Hartemann-Heurtier A; Grimaldi A
Diabetes Metab; 2007 Sep; 33(4):316-20. PubMed ID: 17466560
[TBL] [Abstract][Full Text] [Related]
19. Consensus on "Basal insulin in the management of Type 2 Diabetes: Which, When and How?".
Ghosal S; Sinha B; Majumder A; Das AK; Singh AK; Ghoshdastidar B; Maji D; Goyal G; Mukherjee JJ; Gangopadhyay KK; John M; Chatterjee S; Jaggi S; Ray S; Majumdar S; Sharma SK
J Assoc Physicians India; 2017 Jul; 65(7):51-62. PubMed ID: 28792170
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of prandial premixed therapy using insulin lispro mix 50/50 3 times daily compared with progressive titration of insulin lispro mix 75/25 or biphasic insulin aspart 70/30 twice daily in patients with type 2 diabetes mellitus: a randomized, 16-week, open-label study.
Farcasiu E; Ivanyi T; Mozejko-Pastewka B; Birkus Z; Csog J; Kowalska I; Coetzer TF; Bulgurlu S; Schinzel B; Kiljanski J
Clin Ther; 2011 Nov; 33(11):1682-93. PubMed ID: 22036246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
